Paper42577005
Bionic intelligent responsive barbed microneedles synergistically remodel the microenvironment for the treatment of refractory pigmentation disorders (melasma).
Ding H and 13 others. Mater Today Bio, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Bionic intelligent responsive barbed microneedles synergistically remodel the microenvironment for the treatment of refractory pigmentation disorders (melasma). Papers, record 42577005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42577005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bionic intelligent responsive barbed microneedles synergistically remodel the microenvironment for the treatment of refractory pigmentation disorders (melasma).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37445612 | Adipose Tissue-Derived Mesenchymal Stem Cell-Derived Exosomes Promote Wound Healing and Tissue Regeneration. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445612 | PubMed |
| 2 | 38886773 | Insights into the role of mesenchymal stem cells in cutaneous medical aesthetics: from basics to clinics. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/38886773 | PubMed |
| 3 | 29222629 | Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment. | Am J Clin Dermatol | 2018 | https://conductscience.org/library/papers/29222629 | PubMed |
| 4 | 37242649 | Responsive Microneedles as a New Platform for Precision Immunotherapy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242649 | PubMed |
| 5 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 6 | 30423086 | fastp: an ultra-fast all-in-one FASTQ preprocessor. | Bioinformatics | 2018 | https://conductscience.org/library/papers/30423086 | PubMed |
| 7 | 30809577 | New oral and topical approaches for the treatment of melasma. | Int J Womens Dermatol | 2019 | https://conductscience.org/library/papers/30809577 | PubMed |
| 8 | 41154805 | Unraveling Melasma: From Epidermal Pigmentation to Microenvironmental Dysregulation. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/41154805 | PubMed |
| 9 | 41227372 | Therapeutic and Clinical Potential of Adipose-Derived Stem Cell Secretome for Skin Regeneration. | Cells | 2025 | https://conductscience.org/library/papers/41227372 | PubMed |
| 10 | 34793122 | A Rapid and Facile Separation-Detection Integrated Strategy for Exosome Profiling Based on Boronic Acid-Directed Coupling Immunoaffinity. | Anal Chem | 2021 | https://conductscience.org/library/papers/34793122 | PubMed |
| 11 | 41013717 | Effectiveness of regenerative medicine for skin lightening and rejuvenation: a systematic review of extracellular vesicles and conditioned media. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41013717 | PubMed |
| 12 | 41799953 | A multimodal ROS logic-gated therapeutic platform disrupts the vicious cycle of senescence to promote aged bone defect repair. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41799953 | PubMed |
| 13 | 37101197 | Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37101197 | PubMed |
| 14 | 36527904 | Adipose-derived stem cells exosome and its potential applications in autologous fat grafting. | J Plast Reconstr Aesthet Surg | 2023 | https://conductscience.org/library/papers/36527904 | PubMed |
| 15 | 23749111 | UV radiation and the skin. | Int J Mol Sci | 2013 | https://conductscience.org/library/papers/23749111 | PubMed |
| 16 | 39308160 | 3D-Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39308160 | PubMed |
| 17 | 38516531 | Extracellular vesicles derived from mesenchymal stem cells: the wine in Hebe's hands to treat skin aging. | Precis Clin Med | 2024 | https://conductscience.org/library/papers/38516531 | PubMed |
| 18 | 39712070 | Design and fabrication of a parasite-inspired, millimeter-scale tissue anchoring mechanism. | PNAS Nexus | 2024 | https://conductscience.org/library/papers/39712070 | PubMed |
| 19 | 28681382 | Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients. | Int J Dermatol | 2017 | https://conductscience.org/library/papers/28681382 | PubMed |
| 20 | 38843906 | Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials. | J Dermatolog Treat | 2024 | https://conductscience.org/library/papers/38843906 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42577005
GET https://conductscience.org/api/papers/v1/42577005/references?page=2